Trial Profile
To compare the pharmacokinetics of single chain recombinant factor VIII with full length recombinant factor VIII in patients with severe haemophilia A
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- 17 Mar 2017 New trial record